Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy

Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy

US Patent 11414708 · Granted Aug 16, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of immune cell-specific gene expression for prognosis of prostate cancer and2025
Use of immune cell-specific gene expression for prognosis of prostate cancer and2025
Systems and methods for preprocessing target data and generating predictions usi2025
Systems and methods for preprocessing target data and generating predictions usi2025
Antibodies or antigen-binding fragments that bind to OX402024
Subtyping prostate cancer to predict response to hormone therapy2024
Subtyping prostate cancer to predict response to hormone therapy2024
Subtyping prostate cancer to predict response to hormone therapy2024
Subtyping prostate cancer to predict response to hormone therapy2024
Oral GSNOR inhibitor and pharmaceutical use thereof2023
Molecular subtyping, prognosis, and treatment of bladder cancer2021
Molecular subtyping, prognosis, and treatment of bladder cancer2021